PeterMichaelVarunokMD

Gastroenterology • Poughkeepsie, NY

Physician

Join to view full profile

Dr. Varunok is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Varunok's full profile

Already have an account?

Office
243 North Rd
Ste 304
Poughkeepsie, NY 12601
Phone+1 845-471-9410

Fax+1 845-451-7757
Is this information wrong?

Education & Training

New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Gastroenterology, 1991 - 1993
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1988 - 1991
State University of New York Downstate Medical Center College of MedicineClass of 1988

Certifications & Licensure

NY State Medical License 1990 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MEDENT EMR/EHR, Community Computer Service, Inc., 2011-2013
Fellow (AGAF) American Gastroenterological Association, 2006

Clinical Trials

Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin Start of enrollment: 2009 Feb 01
Completed
Not Applicable
The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
Completed
Phase 3
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis Start of enrollment: 2014 Apr 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

67 citations
Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without...
Eric Lawitz, Mihály Makara, Ulus Salih Akarca, Paul J. Thuluvath, Liliana Preotescu, Peter Varunok, Rosa M.-ª. Morillas, Coleen Hall, N. Mobashery, Rebecca Redman, Tam...> ;Gastroenterology. 2015 Oct 1
105 citations
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine
Jacob Lalezari, J. Greg Sullivan, Edward Galen, Kris V. Kowdley, Vinod K. Rustgi, Humberto Aguilar, Franco Felizarta, Barbara H. McGovern, M. King, Akshanth R. Polepal...> ;Journal of Hepatology. 2015 Aug 1
498 citations
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson, James N. Cooper, Jacob Lalezari, Eric Lawitz, Paul J. Pockros, Norman Gitlin, B. Freilich, Ziad Younes, William Harlan, Reem Ghalib, Godson Oguchi, Pa...> ;Hepatology. 2015 Apr 1
4 citations
Evaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device.
Peter Varunok, Eric Lawitz, Kimberly L Beavers, Gary Matusow, Ruby Leong, Nathalie Lambert, Coen Bernaards, Jonathan Solsky, Barbara J. Brennan, Cynthia Wat, Anne Bert...> ;Patient Preference and Adherence. 2011 Nov 24
Join now to see all

Press Mentions

Health: Should I Be Tested for Hepatitis C?September 12th, 2017

Professional Memberships

American Gastroenterological Association - AGA
Fellow

Hospital Affiliations

Montefiore St. Luke's CornwallNewburgh, New York
Vassar Brothers Medical CenterPoughkeepsie, New York
MidHudson Regional Hospital of Westchester Medical CenterPoughkeepsie, New York